Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Nelson

Showing results (281-290 of 442) with videos related to

Pageof 45
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2005
Simultaneous targeting of CD3 on T cells and CD40 on B or dendritic cells augments the antitumor reactivity of tumor-primed lymph node cellsQiao Li, Amelia C Grover, Elizabeth J Donald, et al.
AIDS (London, England)|June 6, 2013
Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSMThomas C S Martin, Natasha K Martin, Matthew Hickman, et al.
AIDS (London, England)|December 15, 2010
A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected populationMark Nelson, Hans-Jürgen Stellbrink, Daniel Podzamczer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal diseaseMelanie Hart, Alan Steel, Sally A Clark, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 21, 2004
Use of viral load measured after 4 weeks of highly active antiretroviral therapy to predict virologic outcome at 24 weeks for HIV-1-positive individualsColette J Smith, Schlomo Staszewski, Caroline A Sabin, et al.
Neurology. Clinical Practice|August 2, 2023
Counseling on the Need for Folic Acid in Adolescents With EpilepsyCharmaine B Lo, Bailey Conrad, Andrea Debs, et al.
Journal of Neurovirology|June 6, 2020
Changes in functional connectivity in people with HIV switching antiretroviral therapySofia Toniolo, Mara Cercignani, Borja Mora-Peris, et al.
Blood|November 8, 2003
Antibody-targeted MHC complex-directed expansion of HIV-1- and KSHV-specific CD8+ lymphocytes: a new approach to therapeutic vaccinationJustin Stebbing, Brian Gazzard, Steve Patterson, et al.
Antiviral Therapy|April 14, 2010
Treatment of acute HCV infection in HIV-positive patients: experience from a multicentre European cohortMartin Vogel, Stéphanie Dominguez, Sanjay Bhagani, et al.
The Journal of Infectious Diseases|December 16, 2003
Enfuvirtide (T-20) cross-reactive glycoprotein 41 antibody does not impair the efficacy or safety of enfuvirtideSharon Walmsley, Keith Henry, Christine Katlama, et al.
Pageof 45

Showing results (281-290 of 442) with videos related to

Sort By:
Pageof 45
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2005
Simultaneous targeting of CD3 on T cells and CD40 on B or dendritic cells augments the antitumor reactivity of tumor-primed lymph node cellsQiao Li, Amelia C Grover, Elizabeth J Donald, et al.
AIDS (London, England)|June 6, 2013
Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSMThomas C S Martin, Natasha K Martin, Matthew Hickman, et al.
AIDS (London, England)|December 15, 2010
A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected populationMark Nelson, Hans-Jürgen Stellbrink, Daniel Podzamczer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal diseaseMelanie Hart, Alan Steel, Sally A Clark, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 21, 2004
Use of viral load measured after 4 weeks of highly active antiretroviral therapy to predict virologic outcome at 24 weeks for HIV-1-positive individualsColette J Smith, Schlomo Staszewski, Caroline A Sabin, et al.
Neurology. Clinical Practice|August 2, 2023
Counseling on the Need for Folic Acid in Adolescents With EpilepsyCharmaine B Lo, Bailey Conrad, Andrea Debs, et al.
Journal of Neurovirology|June 6, 2020
Changes in functional connectivity in people with HIV switching antiretroviral therapySofia Toniolo, Mara Cercignani, Borja Mora-Peris, et al.
Blood|November 8, 2003
Antibody-targeted MHC complex-directed expansion of HIV-1- and KSHV-specific CD8+ lymphocytes: a new approach to therapeutic vaccinationJustin Stebbing, Brian Gazzard, Steve Patterson, et al.
Antiviral Therapy|April 14, 2010
Treatment of acute HCV infection in HIV-positive patients: experience from a multicentre European cohortMartin Vogel, Stéphanie Dominguez, Sanjay Bhagani, et al.
The Journal of Infectious Diseases|December 16, 2003
Enfuvirtide (T-20) cross-reactive glycoprotein 41 antibody does not impair the efficacy or safety of enfuvirtideSharon Walmsley, Keith Henry, Christine Katlama, et al.
Pageof 45